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2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or contain-
ing TCDD and the test compounds. The chicken embryos 
and organs were analyzed after 7 and 13 days. The levels 
at which AhR and cyclooxygenase-2 (COX-2) proteins 
(which are induced during inflammation) were expressed 
were evaluated by performing immunohistochemical analy-
ses on embryos treated with TCDD alone or with TCDD 
and the test compounds. TCDD caused developmental dis-
orders and increased AhR and COX-2 expression in the 
chicken embryo tissues. Vitamin E, levamisole, ASA, and 
ASA plus vitamin E inhibited AhR and COX-2 expression 
in embryos after 7 days and decreased AhR and COX-2 
expression in embryos after 13 days. ASA, levamisole, and 
ASA plus vitamin E weakened the immune response and 
prevented multiple organ changes. Vitamin E was not fully 
protective against developmental changes in the embryos.
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Introduction
Polychlorinated dibenzo-p-dioxins and dibenzofurans 
(dioxins) are hazardous chemicals that are classed as per-
sistent organic pollutants. Dioxins are persistent toxins, 
with half-lives of 7–8 years in humans. Dioxins are resist-
ant to degradation in the environment, can be transported 
long distances in the air, and directly threaten environ-
mental and human health (Całkosin´ski et al. 2011; Wrb-
itzky et al. 2001). Dioxins containing between four and six 
chlorine atoms per molecule, such as 2,3,7,8-tetrachlorod-
ibenzo-p-dioxin (TCDD), are some of the most toxic man-
made chemicals (Goldstone and Stegeman 2006; Stec et al. 
2012).
Abstract Polychlorinated dibenzo-p-dioxins and diben-
zofurans (dioxins) are classed as persistent organic pollut-
ants and have adverse effects on multiple functions within 
the body. Dioxins are known carcinogens, immunotoxins, 
and teratogens. Dioxins are transformed in vivo, and inter-
actions between the products and the aryl hydrocarbon 
receptor (AhR) lead to the formation of proinflammatory 
and toxic metabolites. The aim of this study was to deter-
mine whether α-tocopherol (vitamin E), acetylsalicylic acid 
(ASA), and levamisole can decrease the amount of dam-
age caused by dioxins. Fertile Hubbard Flex commercial 
line chicken eggs were injected with solutions containing 
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Humans can be exposed to dioxins through skin contact 
(typically 2% of total exposure), inhaling air (typically 8% 
of total exposure), and ingesting contaminated water or 
food (typically 90% of total exposure) (Całkosin´ski et al. 
2011). Inhaled dioxins mostly enter the body adsorbed 
onto particles of smoke and dust that become phagocyt-
ized by pneumocytes. The penetration of dioxins through 
the skin is facilitated by the lipid layer of the skin coming 
into direct contact with soot, ash, or contaminated clothing 
(Całkosin´ski et al. 2005). Dioxins are lipophilic, so accu-
mulate in fat within biota. Humans are primarily exposed to 
dioxins through ingesting food containing dioxins (Travis 
and Nixon 1991). Dioxins mainly accumulate in the liver 
and in adipose tissue. In experiments using laboratory ani-
mals, dioxins have also been found to accumulate in the 
skin and muscles (Z˙ukiewicz-Sobczak et al. 2012).
Dioxins cause a range of toxic effects in different spe-
cies by activating the aryl hydrocarbon receptor (AhR). 
In the absence of a suitable ligand, the AhRs are found in 
the cytoplasm complexed with chaperones. Once a dioxin 
molecule binds to an AhR–chaperone complex the com-
plex undergoes a conformational change and is transported 
to the nucleus. There, the AhR–chaperone complex dis-
sociates, the dioxin molecule binds to the AhR, and the 
ligand–receptor complex forms a heterodimer with the 
AhR nuclear translocator protein. The heterodimer then 
binds to the xenobiotic response element (also called the 
dioxin response element), which is a specific enhancer 
sequence on a strand of DNA. The xenobiotic response ele-
ment/dioxin response element is in the promoter region of 
the cytochrome P-450 CYP1A1 gene (Mimura and Fujii-
Kuriyama 2003; Niemira et al. 2009; Walker et al. 1997). 
Activation of the promoter causes the transcription of genes 
responsible for metabolizing drugs and xenobiotics and 
ultimately causes metabolic changes and increased enzy-
matic activation of carcinogens (Strucin´ski et al. 2011). 
The dioxin response element regulatory sequence is also 
present in other genes induced by the AhR, called the AhR 
gene battery (Niemira et al. 2009; Williams et al. 2005). 
It is believed that the physiological activator of the AhR 
induces fast on/off switching of signal transduction but that 
dioxin-induced toxicity is caused by the AhR being con-
tinually activated, disturbing homeostasis. In the absence 
of dioxins, the AhR plays roles in regulating the cell cycle 
and suppressing tumors (Marlowe and Puga 2005) and in 
controlling cell proliferation and differentiation (Akahoshi 
et al. 2006; Quintana et al. 2008; Tijet et al. 2006; Walisser 
et al. 2005). It has been found that TCDD causes a wide 
range of biochemical and toxicological effects, includ-
ing teratogenicity and immunosuppression. TCDD also 
affects the expression of genes that control the synthesis 
and metabolism of enzymes, hormones, and growth fac-
tors. Dioxins therefore ultimately affect the reproductive, 
nervous, immune, and endocrine systems (Strucin´ski et al. 
2011).
It has recently been found that dioxins have proinflam-
matory and multidirectional effects that stem from free 
radicals being produced when dioxins undergo epoxida-
tion, dechlorination, and hydroxylation reactions and from 
the stimulation of cyclooxygenase-2 (COX-2) (Rosin´czuk 
and Całkosin´ski 2015). Lim et al. (2007) found that TCDD 
induces oxidative stress related to the generation of reactive 
oxygen species in various organs but decreases the concen-
trations of antioxidant enzymes, such as catalase, superox-
ide dismutase, glutathione reductase, and glutathione per-
oxidase. Hassoun et al. (2004) found that TCDD causes the 
production of superoxide anions, the peroxidation of lipids, 
and damage to DNA in liver and brain cells. Elevated levels 
of proinflammatory cytokines such as interleukin-1, inter-
leukin-6, and particularly tumor necrosis factor have been 
found in animals treated with dioxins (Całkosin´ski 2008). 
These molecules stimulate COX-2 activity, leading to the 
biosynthesis of proinflammatory prostaglandins and throm-
boxanes (Hla and Neilson 1992). Prostaglandins can modu-
late cell adhesion, immune response, mitogenesis, cell pro-
liferation, apoptosis, and angiogenesis processes. Increased 
COX-2 activity, increasing prostaglandin generation, is 
therefore involved in maintaining the inflammatory process 
and intensifying carcinogenesis (Majka et al. 2009). Tera-
oka et al. (2009) found that increased prostaglandin con-
centrations cause circulatory failure to occur in the brains 
of developing zebrafish, causing functional disorders and 
destructive changes such as apoptosis and increased albu-
min permeability in the mesencephalic vein.
In the study described here, we examined the negative 
effects of TCDD on embryogenesis in a chick embryo 
model. The model is objective because the effects of exter-
nal factors and manipulations that can affect the results of 
an experiment are limited. Moreover, injecting test com-
pounds once into the yolk (which is used by the embryo to 
provide energy) ensures that the test compounds are fully 
absorbed by the developing embryo. This makes it possible 
to determine the effects of different agents on the develop-
ing tissues and organs in different stages of embryogen-
esis. It has previously been found that the exposure of an 
embryo to TCDD affects hatchability and causes early or 
late embryonic death (Blankenship et al. 2003). Head et al. 
(2008) analyzed experimental data produced by a num-
ber of researchers and found an LD50 of 0.18 μg/kg for 
chickens, indicating that chickens are very sensitive to 
dioxins. Exposing bird embryos to dioxins causes structural 
and functional defects in the developing heart. It has been 
found that these defects include fewer coronary arteries 
forming, decreased luminal surface areas of the developing 
coronary arteries, and pathological leakages from the vas-
cular system. Dioxins inhibit the growth of cardiomyocytes 
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and affect the abilities of ventricular walls to prolifer-
ate (Ivnitski-Steele et al. 2004; Walker and Catron 2000). 
Blankenship et al. (2003) found that exposure to TCDD 
causes developmental abnormalities including edema, liver 
necrosis, and deformations of the eyes and extremities of 
the body.
Prolonged exposure to dioxins, the accumulation of 
dioxins in adipose tissue, and the slow elimination of diox-
ins from the body make the negative effects of dioxins 
very persistent. It is therefore important that substances are 
found that can protect against the negative effects of diox-
ins. The proinflammatory effects of TCDD can be elimi-
nated using antioxidant compounds, such as α-tocopherol 
(vitamin E), or nonsteroidal anti-inflammatory drugs such 
as acetylsalicylic acid (ASA) (Całkosin´ski et al. 2014). It 
has previously been found that these pharmaceuticals are 
AhR antagonists that can inhibit the inflammatory reactions 
induced by dioxins (Kloser et al. 2011; MacDonald et al. 
2004). Interest in levamisole and its immunomodulatory 
capacity has recently increased. Tests on cows and pigs 
have shown that levamisole can affect both primary and 
secondary immune responses and can restore the proper 
functions of effector cells during an immune response 
(Obmin´ska-Domoradzka and Całkosin´ski 1994; Sajid et al. 
2006). However, no information on the ability of levami-
sole to protect against the effects of exposure to dioxins is 
available.
Materials and methods
Ethical approval was not required for this study according 
to the EU Directive of September 22, 2010, on the protec-
tion of animals used for scientific purposes (2010/63/UE) 
and the Polish Act of January 15, 2015, on the protection of 
animals used for scientific or educational purposes (Polish 
Journal of Laws of 2015, item 266). All of the procedures 
involving animals were performed in accordance with the 
ethical standards of the institution or practice at which the 
studies were conducted.
Chemicals
A standard solution containing 1 µg/ml TCDD (DD-
2378-S; Greyhound Chromatography and Allied Chemi-
cals, Birkenhead, UK) in 1% dimethyl sulfoxide (DMSO) 
was prepared. A solution of 500 mg of ASA (aspirin) 
(Hasco-Lek, Wrocław, Poland) in 833 μl of 1% DMSO 
was prepared. A 1 ml aliquot of a solution contain-
ing vitamin E as α-tocopherol acetate (Hasco-Lek) 
was mixed with 800 μl of 1% DMSO to give a final 
α-tocopherol acetate concentration of 300 mg/ml. An 
aqueous 10% levamisole (Vetoquinol Biowet, Gorzów 
Wielkopolski, Poland) solution was prepared. An aque-
ous 1% DMSO solution was used in the experiments. A 
4% formalin solution buffered with phosphate buffer at 
pH 7.0 was used. Serotec rabbit anti-human AhR anti-
bodies (AHP1107; Bio-Rad Laboratories, Hercules, CA, 
USA) and rabbit anti-mouse COX-2 antibodies (160126; 
Cayman Chemical Company, Ann Arbor, MI, USA) were 
used in the experiments.
Experimental groups
Hubbard Flex line chicken eggs with a mean weight of 
60 g were divided into seven groups. Each egg in six of the 
groups was injected with a test solution before being incu-
bated. The groups and treatments are described below.
1. Control group—not injected—58 eggs.
2. Control Group 2—injected with 5 μl of 1% DMSO—
60 eggs.
3. Injected with 5 μl of the TCDD standard solution 
(5 ng/egg, equivalent to 0.08 ng/g)—60 eggs.
4. Injected with 5 μl of the TCDD standard solution and 
10 μl of the vitamin E solution (1.8 mg/egg, equivalent 
to 30 µg/g)—60 eggs.
5. Injected with 5 μl of the TCDD standard solution and 
1.5 μl of the levamisole solution (0.15 mg/egg, equiva-
lent to 2.5 µg/g)—59 eggs.
6. Injected with 5 μl of the TCDD standard solution and 
5 μl of the ASA solution (3 mg/egg, equivalent to 
50 µg/g)—60 eggs.
7. Injected with 5 μl of the TCDD standard solution, 
10 μl of the vitamin E solution, and 5 μl of the ASA 
solution—59 eggs.
The TCDD dose was determined after inspecting previ-
ously published data (Cohen-Barnhouse et al. 2011; Hen-
shel et al. 1997). The vitamin E dose was determined from 
the results of studies by Całkosin´ski (2008) and Całkosin´ski 
et al. (2015), the ASA dose from the results of studies by 
Dobrzyn´ski et al. (2014) and Rosin´czuk and Całkosin´ski 
(2015), and the levamisole dose from the results of stud-
ies by Obmin´ska-Domoradzka and Całkosin´ski (1994) and 
Purzyc and Całkosin´ski (1998).
The surface of each egg shell was disinfected with 70% 
ethanol; then, a small hole was drilled at the blunt end of 
the egg. With the egg horizontally orientated, the specified 
solution was injected into the yolk by inserting the needle 
of a Hamilton syringe through the air chamber to about 
3 cm deep. The needle was then withdrawn and the egg 
vertically orientated before the hole was sealed with melted 
paraffin (Blankenship et al. 2003). The eggs were placed 
in a C-82 incubator (Jartom, Gostyn´, Poland) the day after 
being injected. The incubator was kept at 37.6 °C and 55% 
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humidity, and the eggs were turned 90° every hour. The 
eggs were candled on the seventh and 13th days of incuba-
tion, and the viability of each embryo was assessed. Some 
of the eggs containing living embryos were broken on the 
seventh and 13th days of incubation to allow the embryos 
to be collected and subjected to immunohistochemical 
analyses. Whole embryos were collected on the seventh 
day, and each embryo collected on the 13th day was dis-
sected and the heart, liver, brain, and eyes collected. Each 
tissue sample was fixed in 4% buffered formalin solution 
and stored at 4 °C.
Immunohistochemical analysis
For analysis, a tissue sample (fixed in 4% formalin) was 
washed in running water and then cut into smaller pieces. 
The pieces were then dehydrated by placing them in a 
series of aqueous solutions containing increasing concen-
trations of ethanol (70, 80, 96, then 100%). The pieces 
were then treated with methyl benzoate and embedded in 
paraffin. Each paraffin block was then cut into 5-µm-thick 
sections using a rotary microtome (Slee, Mainz, Ger-
many). Each section was then analyzed to determine the 
degree of AhR and COX-2 expression. The reagents used 
in the immunohistochemical analyses were supplied by 
Dako (Agilent Technologies, Wilmington, DE, USA). 
Each tissue section was incubated at 58 °C overnight; then, 
the paraffin was removed using xylene. The sample was 
then hydrated by placing it in a series of alcohol solutions 
and then washed with distilled water. The sample was then 
subjected to heat-induced epitope retrieval, cooled, and 
washed with distilled water. Endogenous peroxidase was 
neutralized using peroxidase block; then, the slide was 
washed with distilled water and incubated with protein 
block. Primary antibodies (50–100 µl of rabbit anti-human 
AhR antibodies diluted by a factor of 80 and rabbit anti-
mouse COX-2 antibodies diluted by a factor of 300) were 
then applied to the sample, and the sample was incubated 
for 1 h at room temperature. The sample was then washed 
with phosphate-buffered saline, and secondary antibody 
anti-rabbit immunoglobulins, HRP conjugated, were 
applied before the sample was incubated for 30 min. The 
peroxidase activity was developed by incubating the sam-
ple with a mixture containing 3,3ʹ-diaminobenzidine (1 ml 
of 3,3ʹ-diaminobenzidine substrate buffer and one drop of 
3,3ʹ-diaminobenzidine chromogen). The sample was then 
rinsed with distilled water and counterstained with May-
er’s hematoxylin (Chempur, Piekary S´la˛skie, Poland). The 
sample was then washed with tap water, dehydrated in a 
series of ethanol solutions (80, 96, then 100%), washed 
with xylene, and sealed in Canadian balm (Chempur, 
Piekary S´la˛skie, Poland).
Results
AhR expression and the state of embryo development
Seven‑day‑old chicken embryos
The AhR expression and developmental changes in the tis-
sues from the chicken embryos collected on day 7 are sum-
marized in Table 1 and shown in Fig. 1.
The control group (Group 1) embryos collected on day 
7 showed AhR expression, particularly in the mesenchyme 
and dorsal epidermis. The primordia of the spine, ribs, and 
limbs were well developed. The eye epithelium, the other 
auxiliary eye organs, and the brain were in the organiza-
tion phase. The organs in the abdominal cavity were in the 
early stages of development and, like other organs, did not 
show positive reactions. The second control group (Group 
2) embryos, treated with DMSO, showed weak positive 
reactions in the ridge epidermis, the lens and cornea ecto-
dermal epithelia, and the apical zone of the differentiating 
olfactory epithelium.
Positive reactions were shown in most organs in the 
group injected with TCDD (Group 3). AhR expression was 
observed in the dorsal and abdominal epidermis and in the 
surface and internal parts of the eye epithelium (Fig. 1b). 
Weak positive reactions were found in the myoblasts and 
mesenchyme. A strong positive reaction was found on the 
outskirts of the liver, but a weaker reaction was found in the 
central part (Fig. 1c). Similarly, staining was more intense 
in the perichondrium than in cartilage (Fig. 1a). The gray 
matter of the brain lacked AhR expression, and the embryos 
were at an appropriate developmental stage compared with 
the control group. Weak proliferation and positive reactions 
were found in the ependyma cells in the brain. Nothing else 
indicated that embryo development had been delayed.
The embryos in the group injected with TCDD and vita-
min E (Group 4) showed AhR expression in the myoblasts, 
mesenchymal and epidermal cells, and in the surfaces of 
the gray matter of the brain. Positive reactions and develop-
mental disorders were not found in the parenchymal organs 
or nervous system.
The embryos in the group injected with TCDD and lev-
amisole (Group 5) had weaker brain cell migration than in 
the control group. The eye epithelium was slightly thinner 
than in the control group but had a similar level of organi-
zation. The epidermis was only one cell thick but did not 
show a positive reaction. No AhR expression was observed 
in any organ.
The embryos in the group injected with TCDD and ASA 
(Group 6) had normal eye, epidermis, and brain develop-
ment and lacked AhR expression. The kidneys and liver 
had slightly higher levels of organization than in the control 
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group, especially the liver, in which the blood vessels had 
been almost completely closed by rapidly proliferating 
hepatocytes (Fig. 1c). Positive reactions were found in 
some liver and kidney samples.
The embryos in the group treated with TCDD, ASA, 
and vitamin E (Group 7) did not show positive reactions in 
the lens or eye epithelium (Fig. 1b). Development of the 
gray matter of the brain was delayed, but there was a highly 
developed area of migratory cells in the brain. The hypo-
thalamus and medulla oblongata with the proliferative zone 
were further advanced than in the control group. The epi-
dermis was also better developed than in the control group. 
No AhR expression was observed in any of these structures. 
Weak positive reactions were found in the proximal tubules 
of the kidneys.
Thirteen‑day‑old chicken embryos
The AhR expression and developmental changes found 
in the chicken embryos collected on day 13 are presented 
in Table 2. The changes exposure to TCDD caused in the 
heart and liver are shown in Figs. 2 and 3, respectively.
The hearts of the control group (Group 1) embryos had 
different levels of AhR expression in different locations. 
Weak positive reactions were found in the atrial muscle 
cells, but negative reactions were found in the ventricular 
cells. The walls of the atria and ventricles showed different 
levels of myocyte and blood vessel development.
The hearts of the control group with DMSO-added 
(Group 2) embryos had myocyte hypertrophy, the myocytes 
being clearly thicker and more compact than in the control 
group. The vascular bed was decreased compared with the 
control group. Weak positive reactions were found in the 
ventricles and atria, but a negative reaction was found in 
the apex of the heart.
The embryos in the group injected with TCDD (Group 
3) showed very strong AhR expression throughout the heart 
(Fig. 2), but some parts of the apex of the heart showed 
weak positive or negative reactions. The muscle cells 
showed hypertrophy, and the vascular bed was decreased 
compared with the control group.
The embryos in the group injected which TCDD and 
vitamin E (Group 4) showed strong positive reactions 
throughout the heart. Excessive adipose tissue was present, 
and AhR expression was found in this tissue.
Positive reactions were also found in the embryos in the 
group treated with TCDD and levamisole (Group 5), but 
the reactions were weaker than in Groups 3 and 4. AhR 
expression was found in the atrium, myocardium, and adi-
pose tissue cells. Positive reactions were also found at the 
apex of the heart.
Only weak AhR expression was found in the hearts of 
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(Group 6), as is shown in Fig. 2. Positive reactions were 
found in the ventricular myocytes, but a negative reaction 
was found in the atrium.
The embryos in the group injected with TCDD, ASA, and 
vitamin E (Group 7) showed AhR expression throughout 
the heart, but the reaction was less intense than in Group 3 
(Fig. 2). The visible reaction was weaker in the atrium than 
in the ventricles. The heart was less developed than in the 
control group (i.e., hypertrophy of myocytes was not found).
The results found for the liver samples are shown in 
Table 2 and Fig. 3. The livers of the control group (Group 
1) embryos collected on day 13 were at different stages of 
development. Large sinusoidal-type vessels were found in 
many areas, and they formed a network containing blood 
cells. The accompanying hepatocytes were organized into 
the first primitive lobules. Locally very weak positive 
AhR reactions were found in the hepatocytes. The hepato-
cytes were strongly developed in other areas, resulting in 
the lumen of the sinusoidal vessels narrowing, giving the 
appearance of an adult liver.
The embryos in the group with DMSO added (Group 2) 
were less developed than the control group embryos. Sin-
gle cells exhibited very weak AhR expression, but negative 
reactions were mainly found.
Similar hepatic development was observed in the 
embryos in the group injected with TCDD (Group 3) as in 
Fig. 1  Comparison of Ah receptor expression in the selected organs 
and groups of 7-day-old chicken embryos. Control—group 1, 
TCDD—Group 3, TCDD + vit. E—Group 4, TCDD + ASA—Group 
6, TCDD + ASA + vit. E—Group 7. a Cartilage (C) with perichon-
drium (magnification 400). Note the presence of the AhR in the 
TCDD group (arrow); b eye epithelium (E) (magnification ×400). 
Note the increased presence of the AhR in the TCDD group (arrows); 
c liver (L) (magnification ×400). Note the increased presence of the 
AhR in the groups with TCDD (arrows)
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Group 2. Stronger AhR expression was found in the hepat-
ocytes than was found in the other groups, but the positive 
reactions were not uniformly dispersed over the surface of 
the liver (Fig. 3). Fat cells were locally prevalent and were 
visible between the hepatocytes.
The livers from the embryos in the group treated with 
TCDD and vitamin E (Group 4) had areas in which less 
morphological differentiation had occurred than expected, 
and AhR was expressed very weakly in individual cells in 
these areas. Fat droplets and lymphocytic infiltrations were 
found in areas between cells. Hepatocytes in these areas 
showed regressive changes and positive reactions (Fig. 3).
The embryos in the group injected with TCDD and lev-
amisole (Group 5) had well-developed livers similar to 
Table 2  Expression of Ah receptor and developmental changes in different tissues/organs and groups of 13-day-old chicken embryos
−, lack of AhR expression; +/−, weak positive reaction, single cells; +, positive reaction; ++, strong positive reaction; Control, Group 1; 
DMSO, Group 2; TCDD, Group 3; vit. E, Group 4; LVM, Group 5; ASA, Group 6; ASA + vit. E, Group 7
Organ\group Control DMSO TCDD vit. E LVM ASA ASA + vit. E
Heart
 Ventricle − +/− ++ ++ + + +
 Atrium +/− +/− ++ ++ + − +/−




















Single steatosis Single steatosis
Brain
 Gray matter − − +/− +/− +/− − −
 White matter +/− +/− + +/− + +/− +/−
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Less developed 
outer layer of 
gray matter
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Fig. 2  AhR expression in the hearts of the selected groups of 13-day-
old chicken embryos (magnification ×400). Control—Group 1, 
TCDD—Group 3, TCDD + ASA—Group 6, TCDD + ASA + vit. 
E—Group 7. Note the hypertrophied cardiomyocytes with elevated 
AhR expression in TCDD group (arrow)
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mature livers. Positive AhR expression was found in some 
areas in the liver, but the intensity was weaker than in 
Group 3.
Single hepatocytes showed AhR expression in the 
embryos in the group injected with TCDD and ASA (Group 
6). Steatosis in the hepatocytes was observed (Fig. 3), and 
the lobe structure of the liver was locally obliterated.
The livers of the embryos in the group injected with 
TCDD, ASA, and vitamin E (Group 7) were less differ-
entiated than the control group livers. Single cells exhib-
ited AhR expression. Steatosis within the hepatocytes was 
found locally.
The brain tissue results for the samples collected on 
day 13 are shown in Table 2. The correct brain struc-
ture was beginning to form in the embryos in the control 
group (Group 1). The developing brain contained five lay-
ers. Weak positive reactions were observed in areas with 
migrating and proliferating cells and in the ependyma 
cells. Little AhR expression was found in the white mat-
ter, but negative reactions were found in the gray matter. 
Single microglial cells in the mesenchyme showed positive 
reactions.
Spots of AhR expression were found in the white matter 
in the embryos in the control group injected with DMSO 
(Group 2). Weak positive responses were found in individ-
ual cells and in the ependyma and ganglion cells.
The outer gray matter layer was less developed in the 
group injected with TCDD (Group 3) than in the control 
group. Intense AhR expression was found on the brain 
surface. Positive reactions were found in the white matter, 
and positive reactions were found in the gray matter in the 
nerve fiber layer in the internal cerebral cortex. Weak AhR 
expression was found in single mesenchymal cells, but no 
AhR expression was found in the ganglion cells.
The outer gray matter layer was less developed in the 
group injected with TCDD and vitamin E (Group 4) than 
in the control group. AhR expression was found in single 
cells between the cerebral cortex layers and in the internal 
granular layer. Weak positive reactions were found in the 
white matter and in the surface layer of the cerebellum.
A strongly developed future internal pyramidal cell layer 
was found in the group injected with TCDD and levami-
sole (Group 5). AhR expression was visible in single cells 
in the outer layer and the internal granular layer of the gray 
matter. Strong positive reactions were found in the mesen-
chyme, midbrain, and white matter.
No abnormalities were found in the brains of the 
embryos in the group injected with TCDD and ASA (Group 
6), but the outer gray matter layer was less developed than 
in the control group. Positive reactions were found only in 
the white matter cells, and AhR expression was not found 
elsewhere in the brain.
The visible gray matter layer was strongly developed in 
the group treated with TCDD, ASA, and vitamin E (Group 
7), but the brain was less dense than in the other groups. 
AhR expression was found in the neurocytes organized into 
the nucleus of the white matter and in the cerebral cortex, 
but negative reactions were found elsewhere in the brain.
The results for the eye tissues are shown in Table 2. The 
eye epithelium was highly evolved, and no AhR expression 
was found in the control group (Group 1). The eye epithe-
lium in the group treated with DMSO (Group 2) contained 
seven layers, and weak positive reactions were found in the 
surface layer.
Developmental disorders were found in the six-layer eye 
epithelium found in the group injected with TCDD (Group 
3). Weak positive reactions were found in the external gran-
ular layer of the epithelium.
Eye epithelium development was normal in the group 
injected with TCDD and vitamin E (Group 4), and no AhR 
expression was found. The eye epithelium was poorly 
developed and had a low cell density in the group treated 
with TCDD and levamisole (Group 5), and AhR expression 
was not found. Eye epithelium development was normal 
Fig. 3  AhR expression in the livers of the selected groups of 13-day-
old chicken embryos (magnification ×400). Control—Group 1, 
TCDD—Group 3, TCDD + vit. E—Group 4, TCDD + ASA—Group 
6. Note the increased level of AhR expression in TCDD groups. In 
Group 4, degradation of hepatocytes with mild lymphocyte infiltra-
tion (arrow) can be observed
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in the group injected with TCDD and ASA (Group 6), and 
weak positive reactions were found on the surface of the 
epithelium at the retina. The eyes of the group treated with 
TCDD, ASA, and vitamin E (Group 7) were similar to the 
eyes in Group 6, the eye epithelium being properly devel-
oped. However, the surface layer was thick and a low level 
of AhR expression was found.
Effects of TCDD on COX‑2 expression
Seven‑day‑old chicken embryos
The COX-2 expression results are shown in Table 3 and 
Fig. 4.
No COX-2 expression was found in any tissue in the 
control group (Group 1) embryos on day 7, but some liver 
and kidney samples had weak positive reactions. Weak pos-
itive reactions were observed in the kidney and locally in 
the cartilage in the embryos in Group 2 (which had been 
treated with DMSO). No COX-2 expression was found 
in other tissues such as the epidermis, eye epithelium, 
brain, and liver. No COX-2 expression was found in the 
mesenchyme.
Positive reactions were found in the ependyma cells 
of the brain (Fig. 4) and the mesenchyme below the eye 
epithelium in the group injected with TCDD (Group 3). 
COX-2 expression was also found in the cartilage matrix in 
the bone primordia. Weak and sporadic positive reactions 
were found in the liver and kidneys.
Embryos in the group treated with TCDD and vitamin 
E (Group 4) showed weak positive reactions in the mes-
enchyme, bone primordia cartilage, intervertebral gan-
glia, liver, and proximal tubules in the kidney. Only a few 
embryos in the group injected with TCDD and levamisole 
(Group 5) showed weak positive reactions in the liver and 
kidneys. Embryos in the group injected with TCDD and 
ASA (Group 6) showed no COX-2 expression in most 
of the tissues. Weak COX-2 expression was found in the 
ganglion cells and proximal tubule cells in the kidneys. 
Embryos in the group treated with TCDD, ASA, and vita-
min E (Group 7) showed weak positive reactions only in 
the proximal tubules of the nephron.
Thirteen‑day‑old chicken embryos
The COX-2 expression results are shown in Table 4.
Table 3  Expression of COX-2 
in different tissues/organs and 
groups of 7-day-old chicken 
embryos
−, lack of COX-2 expression; +/−, weak positive reaction, single cells; +, positive reaction; Control, 
Group 1; DMSO, Group 2; TCDD, Group 3; vit. E, Group 4; LVM, Group 5; ASA, Group 6; ASA + vit. E, 
Group 7
Organ\group Control DMSO TCDD Vit. E LVM ASA ASA + vit. E
Epidermis − − − − − − −
Eye epithelium − − − − − − −
Mesenchyme − − + +/− − − −
Brain − − +/− − − − −
Cartilage with perichondrium − +/− + +/− − − −
Liver +/− − +/− +/− +/− − −
Kidneys +/− +/− +/− +/− +/− +/− +/−
Fig. 4  COX-2 expression in the brain of the selected groups of 
7-day-old chicken embryos (magnification ×400). Control—Group 
1, TCDD—Group 3, TCDD + ASA—Group 6, TCDD + ASA + vit. 
E—Group 7. Developmental disorders of cerebral cortex (arrows) 
associated with retardation in cell proliferation (Group 7), migration 
and meninges organization (M) (Group 6), and COX-2 expression 
and cell adhesion (Group 3)
532 Histochem Cell Biol (2017) 147:523–536
1 3
The atrial muscle cells of the hearts of the control group 
(Group 1) embryos collected on day 13 expressed COX-2 
weakly, but negative reactions were found in the ventricu-
lar myocardium. COX-2 was not expressed throughout the 
heart in the group treated with DMSO (Group 2), but myo-
cyte atrophy and steatosis were found.
A weak positive response was found in the heart atrium 
in the group injected with TCDD (Group 3), but the ventri-
cles and apex did not express COX-2. Fat cells were found 
between the myocytes.
Mainly negative reactions were found in the group 
injected with TCDD and vitamin E (Group 4). Weak 
expression of COX-2 was only found in the cardiac mus-
cle cells. Slight positive reactions were found in individ-
ual cells in the embryos in the group injected with TCDD 
and levamisole (Group 5), but no COX-2 expression was 
found in most of the heart, although sparse steatosis was 
found between myocytes. A similar COX-2 expression pat-
tern was found in the group treated with TCDD and ASA 
(Group 6), with weak positive reactions only in the atrium 
cells but negative responses being found in the ventricles. 
Similarly, weak positive reactions were only found in the 
atrium in the group injected with TCDD, ASA, and vitamin 
E (Group 7), and no COX-2 expression was found in the 
rest of the heart.
No COX-2 expression was found in the livers of the con-
trol group (Group 1) embryos or the embryos in the group 
treated with DMSO (Group 2), as is shown in Table 4. 
The reverse was found for the group injected with TCDD 
(Group 3), with COX-2 being found in single hepatocytes. 
Lymphocytic infiltrates were also found in the liver.
Numerous lymphocytic infiltrations and necrotic liver 
cells were found in the group treated with TCDD and 
vitamin E (Group 4). Vacuolization was found in many of 
these cells, indicating that the hepatocytes had accumulated 
fat. The characteristic structure of the liver also became 
amorphous and no COX-2 expression was found. The livers 
in the group injected with TCDD and levamisole (Group 5) 
showed positive reactions and sparse steatosis. Blurring of 
the structures and membranes between the hepatocytes and 
weak COX-2 expression were found in the livers from the 
group treated with TCDD and ASA (Group 6). Fatty liver 
cells and weak positive reactions were found in the group 
injected with TCDD, ASA, and vitamin E (Group 7).
No COX-2 expression was found in the brains of the 
control group or the group treated with DMSO (Table 4). 
No COX-2 expression was found in any of the brains from 
the embryos treated with TCDD or TCDD and vitamin E, 
levamisole, ASA, or ASA plus vitamin E.
No COX-2 expression was found in the eyes of the con-
trol group embryos or the embryos treated with DMSO 
(Table 4). No positive staining in any of the eye was found 
in the embryos treated with TCDD or with TCDD and vita-
min E, levamisole, ASA, or ASA plus vitamin E.
Discussion
Dioxins are insidious poisons because they are organolepti-
cally undetectable and are toxic even at low concentrations. 
TCDD at a concentration of 5 µg/kg b.w. has toxic effects 
that manifest themselves even in the second generation of 
experimental animals (Całkosin´ski 2005). For compari-
son, the toxic gas nitrogranulogen is used as a cytostatic 
at a concentration of 600 µg/kg body weight (b.w.) but has 
immunomodulatory properties at a concentration of 5 µg/
Table 4  Expression of COX-2 in different tissues/organs and groups of 13-day-old chicken embryos
−, lack of COX-2 expression; +/−, weak positive reaction, single cells; +, positive reaction; Control, Group 1; DMSO, Group 2; TCDD, Group 
3; vit. E, Group 4; LVM, Group 5; ASA, Group 6; ASA + vit. E, Group 7
Organ\group Control DMSO TCDD Vit. E LVM ASA ASA + vit. E
Heart
 Ventricle − − − − − − −
 Atrium +/− − +/− +/− +/− +/− +/−














tions, areas of 
necrosis
Single steatosis Blurred organ 
structure
Single steatosis
Brain − − − − − − −
Eye − − − − − − −
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kg b.w. Dioxins affect the body in multiple ways, causing 
reproduction and development disorders, immunotoxicity, 
thymus involution, liver damage, and cancer. Moreover, 
dioxin exposure results in the formation of reactive oxy-
gen species that cause oxidative stress in cells and tissues 
and stimulate inflammation. This can lead to DNA damage, 
decreased mitochondrial respiration, and decreased NAD+ 
concentrations (Całkosin´ski 2008; Yoon et al. 2006).
It has been found in numerous studies that the actions 
of dioxins at the molecular level are connected to cyto-
solic AhR, which activates the transcription of many genes, 
particularly xenobiotic metabolizing enzymes, including 
cytochrome P-450 (Brauze et al. 2006). In an experiment 
on chicken embryos performed by Walker et al. (2000), the 
AhR protein was found in nerve ganglia, the heart, skeletal 
and smooth muscle, epithelial tissues, mesenchyme tissues, 
the kidneys, and the liver.
Fernandez-Salguero et al. (1996) proved that the AhR 
plays an important role in the mechanism through which 
dioxins act. They showed that AhR− transgenic mice 
exposed to TCDD at a dose of 2000 µg/kg b.w. did not suf-
fer damage to the heart, thymus, liver, kidney, pancreas, 
spleen, or lymph nodes.
In this study, we found that exposure to TCDD caused 
the AhR to be expressed in the early stages of embryo 
development (on day 7) in the skin, eye epithelium, liver, 
skeletal cartilage primordia, kidneys, brain, and mesenchy-
mal cells. The expression of the AhR in the dorsal skin and 
mesenchymal cells was unchanged at the same time in the 
control group, suggesting that the AhR is involved in devel-
opmental processes. In previous publications, it has been 
indicated that the AhR plays key roles in the proliferation 
and differentiation of cells including T lymphocytes (Quin-
tana et al. 2008), neurons (Akahoshi et al. 2006), hepato-
cytes (Walisser et al. 2005), and cells formed during hemat-
opoiesis (Gasiewicz et al. 2010; Tijet et al. 2006).
Całkosin´ski (2008) exposed rats to TCDD and treated 
the rats for 3 weeks with high tocopherol doses (30 mg/
(kg b.w. days)). They found that tocopherol effectively 
decreased the concentrations of proinflammatory cytokines 
in the serum, limiting inflammation and the damage caused 
by TCDD. The antioxidant properties of vitamin E have 
also been demonstrated in mice exposed to TCDD. Inject-
ing tocopherol in a single dose of 150 mg/kg b.w. and then 
in doses of 40 mg/kg b.w. on five consecutive days signifi-
cantly decreased the symptoms of TCDD poisoning. Treat-
ment with tocopherol has been found to decrease the con-
centration of nitrogen peroxide and decrease the incidence 
of damage to single-stranded DNA (Alsharif and Hassoun 
2004). Kloser et al. (2011) demonstrated that tocopherol is 
antagonistic to TCDD and prevents TCDD from interacting 
with the AhR.
In a recent search for compounds that decrease the nega-
tive effects of dioxins, ASA was identified as a pharmaco-
logical agent that has anti-inflammatory and antioxidant 
properties and that acts as an AhR antagonist. In studies 
using rats and human hepatoma cells, it has been found that 
ASA can block the AhR, preventing dioxins being trans-
formed within the body and having negative effects (Mac-
Donald et al. 2004). ASA also inhibits both COX-1 and 
COX-2, contributing to them being acetylated (Czyz˙ and 
Watała 2005). In our study, vitamin E was used at a dose 
of 30 µg/g egg, and its effect was boosted by the presence 
of ASA at a dose of 50 µg/g egg. The effects of ASA occur 
through changes in AhR and COX-2 expression.
Dioxins affect the immune system, so we explored the 
potential protective effects of levamisole, a known immu-
nomodulator that influences both primary and secondary 
immune responses.
Administering vitamin E decreased AhR expression in 
the organs except the dorsal epidermis, brain, and mes-
enchyme of the embryos collected on day 7. Levamisole 
inhibited AhR expression in all of the organs and simulta-
neously halted the development of the embryos collected 
on day 7. The most important changes in the embryos 
treated with levamisole compared with the control embryos 
were weaker cell migration in the brain and an underde-
veloped ectodermal epithelium. The embryos treated with 
ASA or ASA and vitamin E expressed the AhR only in the 
kidney primordia. The gray matter in the brain was also 
less developed in the embryos treated with ASA and vita-
min E than in the control embryos.
It has been confirmed in numerous studies that diox-
ins are cardiotoxic and hepatotoxic. It has been shown in 
experiments using chicken embryos that TCDD causes 
structural changes in the heart by causing cardiomyocyte 
proliferation disorders (Ivnitski et al. 2001; Walker and 
Catron 2000; Walker et al. 1997). The structural changes 
include interventricular septum defects, cardiac hypertro-
phy, and extension of the ventricle cavity, which is associ-
ated with the heart walls being thinner than in unaffected 
embryos. Hilscherova et al. (2003) found that dioxins 
cause oxidative DNA damage in chicken embryo livers 
by increasing the amounts of reactive oxygen species pro-
duced and depleting glutathione.
In our study, TCDD caused adverse changes in the heart, 
liver, brain, and eyes of the embryos collected on day 13. 
Myocardial hypertrophy, delayed liver development, and 
steatosis in numerous organs were found. The gray mat-
ter in the brain was also less developed in the embryos 
exposed to TCDD than in the control embryos, and devel-
opmental disorders of the eye epithelium were found in the 
embryos exposed to TCDD. AhR expression was found 
in all of the organs and groups, but the most intense AhR 
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expression was found in the group injected with only 
TCDD. ASA was the most effective of the protective sub-
stances used. ASA decreased AhR expression and the nega-
tive effects of TCDD on embryo development, especially 
the development of the heart, liver, and eyes. Similar results 
were found for the group treated with ASA and vitamin E, 
although the protective effects on the heart appeared to be 
slightly weaker than the effects of ASA alone. Levamisole 
had protective effects on organ development and decreased 
AhR expression. Vitamin E had no protective effects on 
organ development in the embryos collected on day 13, and 
the organs from this group had similar developmental lev-
els to the organs from the group injected with only TCDD, 
but slightly less AhR expression was found in the eyes and 
brain.
In previous studies, it has been found that exposure to 
dioxins leads to inflammation. TCDD causes elevated lev-
els of the proinflammatory cytokines interleukin-1, inter-
leukin-6, and tumor necrosis factor and therefore increases 
COX-2 activity. This leads to proinflammatory prostaglan-
dins and thromboxanes being synthesized and the inflam-
mation of tissues (Nishimura et al. 2008).
Weak COX-2 expression was found in the liver and 
kidneys of the embryos collected on day 7. TCDD also 
induced COX-2 expression in the mesenchyme cells, brain, 
and cartilage and perichondrium. The protective substances 
except vitamin E inhibited COX-2 expression in all of the 
organs except the kidneys, but levamisole did not inhibit 
COX-2 expression in the liver.
The embryos collected on day 13 showed COX-2 expres-
sion in the heart atrium and liver. COX-2 expression was not 
found in the brain or eyes of the embryos in any group. The 
protective substances did not inhibit COX-2 expression in 
the embryos collected on day 13. Lipocytes were observed 
within the myocardium in the embryos exposed to TCDD, 
and this may affect the future functioning of the heart. Add-
ing vitamin E, ASA, or ASA plus vitamin E suppressed 
the formation of fat cells between the myocytes. COX-2 
expression in the liver was associated with steatosis occur-
ring between the hepatocytes and lymphocytic infiltration 
and inflammation in the embryos treated with TCDD and 
with TCDD and vitamin E. Lymphocytic infiltrates were not 
observed in the embryos in the other groups even though 
COX-2 expression and visible lipocytes were found. These 
results indicate that ASA, levamisole, and ASA plus vita-
min E have effective immunomodulatory activities and can 
decrease the damage dioxins cause to organs.
Our results support the results of previous studies 
in which dioxins were found to affect AhR and COX-2 
expression in chick embryo tissues (Fujisawa et al. 2014; 
Karchner et al. 2006; Walker et al. 1997). We success-
fully demonstrated that vitamin E, levamisole, and ASA 
modulate the negative effects of TCDD. The protective 
compounds inhibited AhR and COX-2 expression in the 
embryos collected on day 7 but did not have strong pro-
tective effects on the embryos collected on day 13. This 
may be because the injected compounds were metabo-
lized as the embryo developed and because the mass of the 
embryo increased between days 7 and 13, weakening the 
pharmacological effects of the test compounds. However, 
new receptors could be created during embryogenesis that 
reconstitute and develop with organogenesis. This may be 
why some positive reactions were found in the embryos 
collected on day 13. ASA, levamisole, and ASA plus vita-
min E weakened the immune response to TCDD and pre-
vented changes in multiple organs. Vitamin E did not fully 
protect against developmental changes. The main conclu-
sions of the study are summarized below.
•	 TCDD increased AhR and COX-2 expression in the tis-
sues of chicken embryos collected on days 7 and 13 of 
incubation.
•	 TCDD caused developmental abnormalities in the 
chicken embryos, especially in the heart, liver, brain, 
and eyes.
•	 Vitamin E, levamisole, ASA, and ASA plus vitamin E 
inhibited AhR and COX-2 expression in the tissues of 
embryos exposed to TCDD collected on day 7 of incu-
bation and decreased AhR and COX-2 expression in the 
tissues of embryos collected on day 13.
•	 ASA, levamisole, and ASA plus vitamin E weakened 
the immune response and prevented multiple organ 
changes. However, vitamin E did not completely protect 
against changes in the developing embryos.
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